A Study to Assess the Effect of ELX/TEZ/IVA on Glucose Tolerance in Participants With Cystic Fibrosis (CF)
Clinical trial NCT04599465 · COMPLETED
Trial details
- NCT number
- NCT04599465
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-15
- Primary completion
- 2022-07-14
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.